| 产品编号 |
英文名称 |
CAS号 |
产品规格 |
价格 |
货期 |
| ZMR-15-0344 |
(11bR)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[695162-89-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8534 |
(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0348 |
(11bR)-4-Hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[361342-55-4] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8540 |
(11bR)-4-Hydroxy-2,6-bis(adamantan-1-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide, 95% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-1392 |
(11bR)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
[791616-59-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8550 |
(11bR)-4-Hydroxy-9,14-dinitro-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
[1535206-22-4] |
10mg |
咨询 |
3-5周 |
| ZMR-15-0444 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[1225195-02-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1383 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1242066-20-1] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0566 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[934201-93-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0404 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[791616-70-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1378 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[922711-75-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1396 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[791616-65-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0424 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[1011465-23-8] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0436 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(3,5-di-tert-butyl-4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0408 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[1011465-27-2] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0414 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[791616-68-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0394 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[1569807-15-3] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0820 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[957790-94-2] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0573 |
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-5620 |
(11bR)-N,N-Dimethyl-2,6-diphenyl-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98% |
[936010-61-6] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0522 |
(11bR)-N,N-Bis[(R)-(-)-1-(2-methoxyphenyl)ethyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, min. 98% |
[736158-72-8] |
100mg |
咨询 |
1-3天 |
| ZMR-15-5616 |
(11bR)-N,N-Bis[(S)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee) |
[209482-28-0] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5610 |
(11bR)-N-Methyl-N-[(R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98% |
[1021439-57-5] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0354 |
(11bR,11'bR)-2,2'-[Oxybis(methylene)]bis[4-hydroxy-4,4'-dioxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin], 98% (99% ee) |
[1022915-09-8] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1457 |
(11bR)-(+)-4,4-Dibutyl-2,6-bis[3,5-bis(trifluoromethyl)phenyl]-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]phosphepinium bromide, 99% R-MARUOKA CAT P-NB |
[1110711-01-7] |
50mg |
咨询 |
1-3天 |
| ZMR-15-1465 |
(11bS)-(-)-4,4-Di-t-butyl-2,6-bis[3,5-bis(trifluoromethyl)phenyl]-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]phosphepinium bromide, 99% S-MARUOKA CAT P-TB |
[1110711-01-7] |
250mg |
咨询 |
3-5周 |
| ZMR-15-1458 |
(11bS)-(-)-4,4-Dibutyl-2,6-bis[3,5-bis(trifluoromethyl)phenyl]-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]phosphepinium bromide, 99% S-Maruoka CAT P-NB |
[1110711-01-7] |
250mg |
咨询 |
3-5周 |
| ZMR-15-0372 |
(11bS)-2,6-Bis(4-chlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0386 |
(11bS)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0365 |
(11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0382 |
(11bS)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-1369 |
(11bS)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1170736-59-0] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1374 |
(11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0422 |
(11bS)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8525 |
(11bS)-2,6-Bis[2-methoxyphenyl-5-(tert-butyl)]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0352 |
(11bS)-2,6-Bis[3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0559 |
(11bS)-2,6-Bis[3,5-bis(1,1-dimethylethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
[1442645-05-7] |
25mg |
咨询 |
3-5周 |
| ZMR-15-1377 |
(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0342 |
(11bS)-2,6-Bis[4-(1,1-dimethylethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1217901-32-0] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0390 |
(11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8521 |
(11bS)-2,6-Bis[4-(9-anthracenyl)-2,6-bis(isopropyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
[1051435-82-5] |
10mg |
咨询 |
3-5周 |
| ZMR-15-0568 |
(11bS)-2,6-Bis[4-(tert-butyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0569 |
(11bS)-4-Oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-1389 |
(11bS)-4-Hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[929097-93-8] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1387 |
(11bS)-4-Hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[874948-59-1] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0308 |
(11bS)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1374030-19-9] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0346 |
(11bS)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[878111-16-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8535 |
(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide, 98%, (99% ee) |
[1639447-03-2] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0317 |
(11bS)-4-Hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1496637-05-8] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1393 |
(11bS)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
[1264573-23-0] |
100mg |
咨询 |
3-5周 |
